Main content 1 Menu 2 Search 3 Footer 4
+A
A
-A
High contrast
HOME JOURNAL CRITERIA NETWORK HELP ABOUT

Current criteria:

Regional:

WPRlM journal selection criteria(2023)

Minimum standards for the suspension and removal of WPRIM approved journals

Countries journal selection criteria:

Philippines

Submit your journal information>

Contact NJSCs>

Korean Journal of Gynecologic Oncology and Colposcopy

1990  to  Present  ISSN: 1226-1742

Articles

About

Year of publication

Save Email

Sort by

Best match
Relevance
PubYear
JournalTitle

DISPLAY OPTIONS

Format:

Per page:

Save citations to file

Selection:

Format:

Create file Cancel

Email citations

To:

Please check your email address first!

Selection:

Format:

Send email Cancel

365

results

page

of 37

1

Cite

Cite

Copy

Share

Share

Copy

A Case of Primary Carcinoma of Fallopian Tube.

Jong Mo PARK ; Mee Kyung AHN ; Soo Nyung KIM ; Sang Yoon KIM

Korean Journal of Gynecologic Oncology and Colposcopy.1993;4(3):107-113.

Primary carcinoma of fallopian tube is very rare tumor, that has an incidence less than 1% in all female genital malignanciea. Yhe symptoms are not distinctive, and in moat cases, they are so slight that the disease is well advanced when the diagnosis is made. The postmenopausal bleeding is the most common presenting eomplaint. The diagnosis of carcinoma of the fallopian tube is not made preoperatively in most cases. A 57 years woman presented with complainta of postmenopausal bleeding for 1 month. This paper reports a case of primary fallopian tube carcinoma and presents literature review.
Diagnosis ; Fallopian Tubes* ; Female ; Hemorrhage ; Humans ; Incidence

Diagnosis ; Fallopian Tubes* ; Female ; Hemorrhage ; Humans ; Incidence

2

Cite

Cite

Copy

Share

Share

Copy

Each Case of Benign and Malignant Mucocele of the Appendix.

Yong Bum PARK ; Ji Soo HAN ; Joo Hak LEE ; Dae Joon CHUN ; Joo Hyun NAM ; Jung Eun MOK

Korean Journal of Gynecologic Oncology and Colposcopy.1993;4(3):99-106.

Mucocele of the appendix is uncomrnon and rarely diagnosed preoperatively. The malignant rountpart-i.e. mucinous cystadenocarcinoma--has the same grross appearance and many micro scopic features in cornmon wilhe the benign form. It rnay be associated with ovarian mucinous cystadenoma of strikingly similar microscopic appearence. A serious complication is a rupture of the mucoeele resulting in pseudomyxoma peritonei. Each case of benign and malignant mucocelr of the appendix falsely diagnosecl as an oovarian tumor before laparotxumy are presented wilh a brief rieview of the literatures.
Appendix* ; Cystadenoma, Mucinous ; Mucins ; Mucocele* ; Pseudomyxoma Peritonei ; Rupture

Appendix* ; Cystadenoma, Mucinous ; Mucins ; Mucocele* ; Pseudomyxoma Peritonei ; Rupture

3

Cite

Cite

Copy

Share

Share

Copy

A Case of Sertoli-Leydig Cell Tumor Combined with Dermoid Cyst.

Mee Kyung AHN ; Soo Nyung KIM ; in Jae CHO ; Doo Ho KIM

Korean Journal of Gynecologic Oncology and Colposcopy.1993;4(3):92-98.

The Sertoli-Leydig cell tumors are rare ovarian neoplasm representing only 0.1-0.5% of all primary ovarian neoplasms and are composed of sex-cord and stromal elements, that differentiated in a male direction. They are bilatere,l in less than 2% and confined to the ovaries in over 95% of cases. The majority(about two-thirds) of the reported cases are moderately or poorly differentiated Sertoli-Leydig cell tumors. We experienced one case of Sertoli-Leydig cell tumor combined with derrnoid cyst and reported this case with a review of the litenture.
Dermoid Cyst* ; Female ; Humans ; Male ; Ovarian Neoplasms ; Ovary ; Sertoli-Leydig Cell Tumor*

Dermoid Cyst* ; Female ; Humans ; Male ; Ovarian Neoplasms ; Ovary ; Sertoli-Leydig Cell Tumor*

4

Cite

Cite

Copy

Share

Share

Copy

Two Cases of Clear Cell Carcinoma of Ovary.

Chang Jin JEONG ; Ki Hong CHANG ; Yoon Ho LEE ; Jang Ho LEE

Korean Journal of Gynecologic Oncology and Colposcopy.1993;4(3):86-91.

Clear cell carcinoma of ovary is a rare epithelial ovarian tumor, and increased in its incidence recently. Clear cell carcinoma of ovary was known t,o be highly malignant than other epithelial ovarian tumors. The clinical and pathologic findings of two casea af clear cell carcinoma of ovary are reported and reviewed briefly.
Female ; Incidence ; Ovary*

Female ; Incidence ; Ovary*

5

Cite

Cite

Copy

Share

Share

Copy

A Case of Ovarian Mullerian Mucinous Papillary Cystadenoma of Borderline Malignancy.

Jong Chan PARK ; Jung Hee AHN ; Kyu Wan LEE

Korean Journal of Gynecologic Oncology and Colposcopy.1993;4(3):79-85.

Mullerian Mucinous papillary Cyatadenernas of Borderline tumor(MMBT) is lined by mucinous epithelium of endocervical type and is characterized by papillae architecturally similer to those of serous horderline tumors, It has been described rarely in the literature, Thia case was reported with a brief review of the concerened literatures. It has important clinical and pathological diBerences from mucinous birderline tumors with intestinal differentiation, but has many similatities to mixed epithelial borderline tumora of Mulierian type. Recently, a case of MMBT in a 22 years old woman was experienced at our department. We presented this case with a brief review of literature.
Cystadenoma, Papillary* ; Epithelium ; Female ; Humans ; Mucins* ; Young Adult

Cystadenoma, Papillary* ; Epithelium ; Female ; Humans ; Mucins* ; Young Adult

6

Cite

Cite

Copy

Share

Share

Copy

Combination Chemotherapy for Malignant Ovarian Germ Cell Tumors.

Min Yong LEE ; Tae Sung LEE ; Joon Kyu YEO ; Hae Young SHIN ; Hyung Jong LEE ; Soon Do CHA ; Young Wook SUH

Korean Journal of Gynecologic Oncology and Colposcopy.1993;4(3):71-78.

Thirteen patients with malignant germ cell tumars of the ovary have been treated with a combination chemotherapy. The age of the patients ranged from ll to 50 years and there was no history of radiation therapy of chemotherapy except operation, Stage distributions are as follow ; 2 pstients are stage IV, 3 are stage II and remainied 8 are stage I. 4 patients with immature teratama and 2 patients with mixed germ cell tumor received VAC chemotherapy, as primary therapy, and among them 1 lost to follow up but remained 5 cases live without evidence of disease 39 to 83 gnontha. There were 3 patients with endodermal sinus tumor and 1 received VAC and remeined 2 received FVB as primary chemotherapy, Of them 1 died of disease after 9 months of oyeration and the other 2 live now with no evidence of disease. There were 2 patiente with dysgerminoma and 2 with primary ovarian choriocarcinoma. 1 patient with dysagerminoma and 1 wit choriocarcinoma were died because of chemotherapy toxicity, 1 patient with dysgerminoma, who refused further ehemotherapy after l course of chemot.herapy, died of progressive disease. l patient wit choriocarcinoma now live well without evidence of disease at 35 months. The combination chemotherapy using VAC or PVB regimen represents an effective treatment for malignant. germ cell turnars of the ovary and reveals moderate oxicity.
Choriocarcinoma ; Drug Therapy ; Drug Therapy, Combination* ; Dysgerminoma ; Endodermal Sinus Tumor ; Female ; Germ Cells* ; Humans ; Lost to Follow-Up ; Neoplasms, Germ Cell and Embryonal* ; Ovary ; Pregnancy

Choriocarcinoma ; Drug Therapy ; Drug Therapy, Combination* ; Dysgerminoma ; Endodermal Sinus Tumor ; Female ; Germ Cells* ; Humans ; Lost to Follow-Up ; Neoplasms, Germ Cell and Embryonal* ; Ovary ; Pregnancy

7

Cite

Cite

Copy

Share

Share

Copy

Hematologic Monitoring in Chemotherapy for Patients with Gynecologic Cancer.

Woo Ig SON ; Seung Hee LEE ; Jae Hoon KIM ; Whi KIM ; Kyung Keum SONG ; Hyun Hong KIM ; Ku Taek HAN ; Hun Young LEE

Korean Journal of Gynecologic Oncology and Colposcopy.1993;4(3):63-70.

A retrogpective review of hematologic rnonitoring involving aggressive chemotherapy was careiyd out ta assese whetber there ia a predictable relatiorship between the white blood ce11 count end the platelet count as a refleetion of bone marrow toxicity and when maximum myeloauppression occur during a treatment program. This data revealed that the white blood cell and granulocyte levels are closely related and that myeloeuppression can oceur during any course of CAP(cyclophosphamide, adriamycin, and cisplatin), VBP(vinblastine, bleomycin, and cisplatin) chemotherspy in gynecological cancer. Thus, for these treatment regimena in gynecoldgical malignancies, the white blood cell and granulocyte count is sufficient for momtoing toxicity and adjusting future courses of chemotherapy. There are no bone merrow depresaions by the treatment regirnens for the gestational trophoblastic disease.
Bleomycin ; Bone Marrow ; Doxorubicin ; Drug Therapy* ; Equidae ; Gestational Trophoblastic Disease ; Granulocytes ; Humans ; Leukocytes ; Platelet Count

Bleomycin ; Bone Marrow ; Doxorubicin ; Drug Therapy* ; Equidae ; Gestational Trophoblastic Disease ; Granulocytes ; Humans ; Leukocytes ; Platelet Count

8

Cite

Cite

Copy

Share

Share

Copy

14 Cases of Nondysgerminomatous Ovarian Germ Cell Tumor.

Jong Chan LEE ; O Soon NAH ; Byoung Gie KIM ; Sang Yoon PARK ; Je Ho LEE ; Eui Don LEE ; Kyung Hee LEE ; Kee Bok PARK

Korean Journal of Gynecologic Oncology and Colposcopy.1993;4(3):50-62.

A clinicopathologic study was per formed on 14 cases of malignant nondysgerminomatous ovari an germ cell tumors(NDOGCT) treated at the department of obstetrics and gynecology in Korea Cancer Center Hospital between Jan. l987 and,Jun. 1992. The results obtained were as follows ; 1. Median age of the patients was 27.5 years (range, 5 to 54) 2.Clinical symptoms presented were abdminal pain(64.3%), abdominal palpable mass(42.9%), abdominal distension(28.5%) in order of frequency. 3. Histopathologically, 7 cases(50%) were irnmature teratoma, 4 cases(28.6%) were endoder mal sinus tumor, 1 case(7.1%) was embryonal cell carcinoma, 2 cases(14.3%) were mixed germ cell tumor. 4. Bystage, 6 casse(42.9%) were in stage I, 1 case(7.1%) in stage Il, 2 cases(14.3%) in stage III, 3 cases(21.4%) in stage IV, and 2 cases(14.3%) in recurrence. 5, Serum alphafetoprotein was elevated in all patients withendodermal sinus tumor or embryonal carcinoma, and serum CA125 was elevated in about one half of the patients with nondysgerminomatous gerrn cell tumr. 6. l0 cases were managed by salpingo-oophorectomy with poatoperative chemotherapy, 3 cases by hysterectamy and salpingo-oophorectomy with postoperative chemotherapy. 7. Durations of follow up ranged 5 to 66 months, in that period, 5 cases were died, 4 cases were alive with disease and 4 casee wero no evidence of disease. 1 case was loat follow up after operation. All 5 patients were alive who had been treated with REP regirnen. In conelusion, prognosis of malignant NDOGCT is still poor in spite of adjuvant chemotherapy following surgery, and study ineluding appropriate chemotherapeutic regimen may be needed.
Carcinoma, Embryonal ; Chemotherapy, Adjuvant ; Drug Therapy ; Follow-Up Studies ; Germ Cells* ; Gynecology ; Humans ; Korea ; Neoplasms, Germ Cell and Embryonal* ; Obstetrics ; Phytolacca dodecandra ; Prognosis ; Recurrence ; Teratoma

Carcinoma, Embryonal ; Chemotherapy, Adjuvant ; Drug Therapy ; Follow-Up Studies ; Germ Cells* ; Gynecology ; Humans ; Korea ; Neoplasms, Germ Cell and Embryonal* ; Obstetrics ; Phytolacca dodecandra ; Prognosis ; Recurrence ; Teratoma

9

Cite

Cite

Copy

Share

Share

Copy

Clinical Study of Borderline Malignant Tumor of Ovary.

Il Soo PARK ; Yoon Soon LEE ; Young Lae CHO ; Sang Sik CHUN ; Tae Bon GOO

Korean Journal of Gynecologic Oncology and Colposcopy.1993;4(3):40-49.

Borderline malignant ovarian tumor are characterized as neoplasrns exhibiting cellular priliferative changes greater than those seen in the benign form, but not showing destnictive invasion of the ovarian strama. We reviewed 14 cases of borderline ovarian tumor who had been diagnosed and treated at Kyung Pook university hospital from 1987 to 1992. We nnalysed the clinical features, treatment and prognosis which were compared to 24 cases of the epithelial ovarian cancer at the same period The most common histological thpe of boderline tumnr was mucinous type (1 l cases, 79%), the next one was serous type (3 cases, 21%). In FIGO stage of Borderline tumor, 11 caseS weve stage I a, 1 with stage II c, 1 with stage gb and 1 with stage lV, and the FIGO stage of 24 cases of ovarian cancer was 8 cases with stage I a, 1 with stage I b, 2 with stage I c, 1 with II c, 2 with stage III a, 1 with stage III b, 7 with stage III c and 2 with stage 1V. The mean age of borderline and malignant tumor was 37.1 and 47.6 years.. 3 cases were being pregnant on the operatian. In the 14 cases of borderline turnor, 7 cases were managed by conservative operation, but 1 case recurred 4 years later so extirpative operation and pastoperative chemotherapy were given. The other 4 cases were managed by extirpative operation but postoperative chemotherapy was given in only 1 patient. Follow up ranged from 7 to 72 months. 12 cases were alive. 2 cases died, one was stage III b, the other was atage IV. This atudy suggeat, that it is neceasary to follow up carefully even the early stage of botderline tumor and manage as oyarian carcinama in the advanced stage.
Drug Therapy ; Female ; Follow-Up Studies ; Humans ; Mucins ; Ovarian Neoplasms ; Ovary* ; Prognosis

Drug Therapy ; Female ; Follow-Up Studies ; Humans ; Mucins ; Ovarian Neoplasms ; Ovary* ; Prognosis

10

Cite

Cite

Copy

Share

Share

Copy

A Clinical Study of 14 Cases of Sarcoma of the Uterus.

Eun Yi LEE ; Ho In YOO ; Nak Woo LEE ; Yong Min KIM ; Tak KIM ; Kyu Wan LEE

Korean Journal of Gynecologic Oncology and Colposcopy.1993;4(3):15-23.

Uterine sarcoma whieh is originated from uterine muscle and/or connective tissues, is very rare malignant tumor and is the most lethel of all primary uterine tumors. This study was undertaken to correlate the clinieal findings, diagnoses, managements and ultimate outcome of each particluar grouy of uterine sarcoma at Depart,ment of Obstetrics and Gynecology in Korea University Hospital. The reaults were as follows, 1. The distribution of uterinesarcomaby histologic type was 5 cases (35.7%) for leiomyosarcoma, 5 cases (35.7%) for endometrial strornal sarcoma and 4 eases (28.6%) for mixed Mullerian tumor, 2. The mean age and yarity were 50.8 years and 3.1. 3. The most common syrrlptorn was irregular vaginal bleeding (64.3%), and lower abdominal pain (21.4%), abdominal palpable mass (14.3%) in order of frequency. 4. The distribution by YIGO clinical atage was 35.7% for stage I, 35.7% for stage II, 7.2% for stage IE and 21.4% for stage lV. The average survival time of each stage of disease was decreased with increasing stage. 5. The mean survival time was decreased with inereasing numbers of mitotic figure per 10 high power fields. 6. The mean survival time according to histologc type was 14.5 months for leiomyoaarcoma, 21.5 months for endometrial stromal marcoma, 5.8 months for malignant mixed Mullerian tumor, respectively.
Abdominal Pain ; Animals ; Connective Tissue ; Diagnosis ; Female ; Gynecology ; Korea ; Leiomyosarcoma ; Mice ; Myometrium ; Obstetrics ; Sarcoma* ; Survival Rate ; Uterine Hemorrhage ; Uterus*

Abdominal Pain ; Animals ; Connective Tissue ; Diagnosis ; Female ; Gynecology ; Korea ; Leiomyosarcoma ; Mice ; Myometrium ; Obstetrics ; Sarcoma* ; Survival Rate ; Uterine Hemorrhage ; Uterus*

Country

Republic of Korea

Publisher

Korean Society of Gynecologic Oncology and Colposcopy

ElectronicLinks

http://ejgo.org

Editor-in-chief

E-mail

Abbreviation

Korean J Gynecol Oncol Colposc

Vernacular Journal Title

대한부인종양콜포스코피학회잡지

ISSN

1226-1742

EISSN

Year Approved

2007

Current Indexing Status

Currently Indexed

Start Year

1990

Description

Current Title

Korean Journal of Gynecologic Oncology
Journal of Gynecologic Oncology

Related Sites

WHO WPRO GIM

Help Accessibility
DCMS Web Policy
CJSS Privacy Policy

Powered by IMICAMS( 备案号: 11010502037788, 京ICP备10218182号-8)

Successfully copied to clipboard.